P2X7 Receptor Expression in Coexistence of Papillary Thyroid Carcinoma with Hashimoto’s Thyroiditis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: This study was aimed at investigating the relation of P2X7 receptor (P2X7R) expression with the clinicopathological features of papillary thyroid carcinoma (PTC) coexisting with Hashimoto’s thyroiditis (HT). Methods: We examined 170 patients (84, PTC with HT; 86, PTC without HT). P2X7R expression was examined by immunohistochemical methods. The staining intensity and patterns were evaluated and scored using a semi-quantitative method. Results: The PTC with HT group was more likely to contain women and had less extrathyroid extension, lymph node (LN) metastasis, lymphovascular invasion, and recurrence than the PTC without HT group. Patients positive for P2X7R had significantly higher frequencies of lymphovascular invasion, extrathyroid extension, LN metastasis, and absence of HT. As shown by multivariate analysis, the expression of P2X7R was significantly higher if HT was absent and extrathyroid extension was present. In the PTC with HT group, the expression of P2X7R was significantly higher in patients with tumor multifocality, lymphovascular invasion, and extrathyroid extension. In the PTC without HT group, the expression of P2X7R was significantly higher in women and those having tumor multifocality. Conclusions: Coexistence of PTC with HT is associated with good prognostic factors, and P2X7Rexpression in PTC was correlated with poor prognostic factors and the absence of HT.
Abstract
Background: This study was aimed at investigating the relation of P2X7 receptor (P2X7R) expression with the clinicopathological features of papillary thyroid carcinoma (PTC) coexisting with Hashimoto’s thyroiditis (HT). Methods: We examined 170 patients (84, PTC with HT; 86, PTC without HT). P2X7R expression was examined by immunohistochemical methods. The staining intensity and patterns were evaluated and scored using a semi-quantitative method. Results: The PTC with HT group was more likely to contain women and had less extrathyroid extension, lymph node (LN) metastasis, lymphovascular invasion, and recurrence than the PTC without HT group. Patients positive for P2X7R had significantly higher frequencies of lymphovascular invasion, extrathyroid extension, LN metastasis, and absence of HT. As shown by multivariate analysis, the expression of P2X7R was significantly higher if HT was absent and extrathyroid extension was present. In the PTC with HT group, the expression of P2X7R was significantly higher in patients with tumor multifocality, lymphovascular invasion, and extrathyroid extension. In the PTC without HT group, the expression of P2X7R was significantly higher in women and those having tumor multifocality. Conclusions: Coexistence of PTC with HT is associated with good prognostic factors, and P2X7Rexpression in PTC was correlated with poor prognostic factors and the absence of HT.
참고문헌 (20)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009", Cancer Research and Treatment, 44(1), pp.11~24 (2012), 대한암학회
- Loh KC, "Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma", J Clin Endocrinol Metab, 84, pp.458~463 (1999)
- Chistiakov DA, "Immunogenetics of Hashimoto’s thyroiditis", J Autoimmune Dis, 2, pp.1~ (2005)
- Schäffler A, "Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma", Eur J Clin Invest, 28, pp.838~844 (1998)
- Singh B, "Coexistent Hashimoto’s thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome", Surgery, 126, pp.1070~1076 (1999)
- Del Rio P, "The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer?", Minerva Endocrinol, 33, pp.1~5 (2008)
- Kim SS, "Coexistence of Hashimoto’s thyroiditis with papillary thyroid carcinoma: the influence of lymph node metastasis", Head Neck, 33, pp.1272~1277 (2011)
- Ralevic V, "Receptors for purines and pyrimidines", Pharmacol Rev, 50, pp.413~492 (1998)
- Slater M, "Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors", Histopathology, 44, pp.206~215 (2004)
- Slater M, "Expression of the apoptotic calcium channel P2X7 in the glandular epithelium", J Mol Histol, 36, pp.159~165 (2005)
- Li X, "Decreased expression of P2X7 in endometrial epithelial pre-cancerous and cancer cells", Gynecol Oncol, 106, pp.233~243 (2007)
- Wang Q, "P2X7 receptor-mediated apoptosis of human cervical epithelial cells", Am J Physiol Cell Physiol, 287, pp.C1349~C1358 (2004)
- Solini A, "Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease?", Endocrinology, 149, pp.389~396 (2008)
- Gu LQ, "Association of XIAP and P2X7 receptor expression with lymph node metastasis in papillary thyroid carcinoma", Endocrine, 38, pp.276~282 (2010)
- 김세훈, "ERG Immunohistochemistry as an Endothelial Marker for Assessing Lymphovascular Invasion", Journal of Pathology and Translational Medicine, 47(4), pp.355~364 (2013), 대한병리학회[DOI]
- Lee JH, "The association between papillary thyroid carcinoma and histologically proven Hashimoto’s thyroiditis: a meta-analysis", Eur J Endocrinol, 168, pp.343~349 (2013)
- Huang BY, "Well-differentiated thyroid carcinoma with concomitant Hashimoto’s thyroiditis present with less aggressive clinical stage and low recurrence", Endocr Pathol, 22, pp.144~149 (2011)
- Giordano C, "Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto’s thyroiditis", Science, 275, pp.960~963 (1997)
- Dardano A, "1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parameters", J Clin Endocrinol Metab, 94, pp.695~698 (2009)
- Beynon V, "Activated human CD4+CD45RO+ memory T-cells indirectly inhibit NLRP3 inflammasome activation through downregulation of P2X7R signalling", PLoS One, 7, pp.e39576~ (2012)